Abstract
This study examined the effects of ketorolac tromethamine (KT) and baicalein (BE) on the levels of inflammatory factors in human synoviocytes. The fibroblast-like synoviocytes (FLS) cells were used to determine the possible regulatory effects of KT and BE (KTBE) on the levels of inflammatory factors in FLS cells. In addition, the levels of TNF-α, IL-6, and IL-1β mRNA expression in FLS cells induced by a TNF-α and IL-1β co-treatment were largely inhibited by a KTBE treatment. The level of FLS cells proliferation was increased by IL-1β and TNF-α, and strongly inhibited by KTBE treatment. The production of oxygen species (ROS) was inhibited by KTBE in FLS cells. KTBE appears to regulate the levels of mRNA that are important for regulating RA progression.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Allen, J. B., Manthey, C. L., and Hand, A. R., Rapid onset of synovial inflammation and hyperplasia induced by transforming growth factor beta. J. Exp. Med., 171, 231–247 (1990).
Buckley, M. T. and Brogden, R. N., Ketorolac: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs., 39, 86–109 (1990).
Dasgupta, B., Corkill, M., Kirkham, B., Gibson, T., and Panayi, G., Serial estimation of interleukin 6 as a measure of systemic disease in rheumatoid arthritis. J. Rheumatol., 19, 22–25 (1992).
Forbes, J. A., Butterworth, G. A., Burchfield, W. H., and Beaver, W. T., Evaluation ketorolac, aspirin and an acetaminophen-codeine combination in post operative oral surgery pain. Pharmacother., 10(suppl.), 77–93 (1990).
Genestier, L., Paillot, R., Fournel, S., Ferraro, C., Miossec, P., and Revillard, J. P., Immunosuppressive properties of methotrexate: Apoptosis and clonal deletion of activated peripheral T cells. J Clin Invest., 102, 322–328 (1998).
Granados-Soto, V., Flores-Murrieta, F. J., Castaneda-Hernandez, G., and Hong, E., Evidence against the participation of μ-and κ-opioid receptors in the analgesic activity of Ketorolac in rats. J. Pharm. Pharmacol., 47, 514–517 (1995).
Hwang, S. Y., Kim, J. Y., Kim, K. W., Park, M. K., Moon, Y., Kim, W. U., and Kim, H. Y., IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-kappaB-and PI3-kinase/Akt-dependent pathways. Arthritis Res. Ther., 6, 120–128 (2004).
Jungel, A., Distler, J. H., Kurowska-Stolarska, M., Seemayer, C. A., Seibl, R., Forster, A., Michel, B. A., Gay, R. E., Emmrich, M., Gay, S., and Distler, O., Expression of interleukin-21 receptor, but not interleukin-21, in synovial fibroblasts and synovial macrophages of patients with rheumatoid arthritis. Arthritis Rheum., 50, 1468–1476 (2004).
Konto, Y. and Kollias, G., Synovial fibroblasts in rheumatoid arthritis: leading role or chorus line. Arthritis Res., 2, 342–343 (2000).
Konttinen, Y. T., Ainola, M., Valleala, H., Ma, J., Ida, H., and Mandelin, J., Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis., 58, 691–697 (1999).
Krause, D., Schleusser, B., Herborn, G., and Rau, R., Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis. Arthritis Rheum., 43, 14–21 (2000).
Lee, M. J., Kim, M., Lee, Y. S., and Shin C. G., Baicalein and baicalin as inhibitors of HIV-1 intergrase. Yakhak Hoeji, 47, 46–51 (2003).
Martel-Pelletier, J., Welsch, D. J., and Pelletier, J. P., Metalloproteases and inhibitors in arthritic diseases. Best Pract. Res. Clini. Rheumatol. 15, 805–829 (2001).
McCarey, D. W., McInnes, I. B., Madhok, R., Hampson, R., Scherbakov, O., and Ford, I., Trial of atorvastatin in rheumatoid arthritis (TARA): double-blind, randomised placebo-controlled trial. Lancet, 363, 2015–2021 (2004).
Miranda-Carus, M., Balsa, E. A., Benito-Miguel, M., Perez de Ayala, C., and Martin-Mola, E., IL-15 and the initiation of cell contact-dependent synovial fibroblast-T lymphocyte cross-talk in rheumatoid arthritis: effect of methotrexate. J. Immunol., 173, 1463–1476 (2004).
Morel, J. C., Park, C. C., and Zhu, K., Signal transduction pathways involved in rheumatoid synovial fibroblast inter-leukin-18-induced vascular cell adhesion molecule-1 expression. J. Biol. Chem., 38, 34679–34691 (2002).
Nishimoto, N., Yoshizaki, K., Miyasaka, N., Yamamoto, K., Kawai, S., and Takeuchi, T., Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody. Arthritis Rheum., 50, 1761–1769 (2004).
O’Hara, D. A., Grangen, R. J., Kinzer, M., and Pemberton, D., Ketorolac tromethamine as compared with morphine sulfate for treatment of postoperative pain. Clin. Pharmacol. Ther., 41, 556–561 (1987).
Pap, T., Muller-Ladner, U., and Gay, R. E., Fibroblast biology: Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res., 2, 361–367 (2000).
Wendling, D., Racadot, E., and Wijdenes, J., Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody. J. Rheumatol., 20, 259–262 (1993).
Yang, J. H. and Lee, N. H., Skin permeation and crosslinking with biological tissue of the hydrolyzed products of gardeniae fructus extracts. J. Kor. Pharm, Sci., 35, 7–16 (2005).
Yee, J., Allison, C., Koshiver, J., and Brown, C. R., Analgesia from intramuscular ketorolac tromethamine compared to morphine sulfate in severe pain following major surgery. Pharmacother., 6, 253–261 (1986).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yang, JH., Yun, MY., Lee, NH. et al. The effects of ketorolac tromethamine and baicalein on the levels of inflammatory factors in human synoviocytes. Arch. Pharm. Res. 31, 1517–1523 (2008). https://doi.org/10.1007/s12272-001-2138-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-001-2138-6